Antioxidant properties of 2-[2-imino-5-nitro-3-(2-oxo-2-phenylethyl)-2,3-dihydro-1H-benzimidazol1-yl]-1-phenylethanone (compound 1) and 2-(4-fluorobenzylidene)-6-(phenylcarbonyl)[1,3]thiazolo[3,2a]benzimidazol-3(2H)-one (compound 2) were evaluated in vitro. Compounds 1 and 2 did not show significant radical scavenging activity. It has been suggested that antioxidant strategies should not be based on direct scavengers but rather on the potentiation of endogenous antioxidant defenses, or on the reduction of the sources of reactive species. Although a direct scavenging mechanism is missing, the assayed compounds (1 and 2) as evidenced inhibitors of xanthine oxidase and dipeptidyl peptidase-4 might act antioxidatively by employing other mechanisms.
References
1.
Arts MJTJ, Haenen GRMM, Voss HP, Bast A. Antioxidant capacity of reaction products limits the applicability of the Trolox Equivalent Antioxidant Capacity (TEAC) assay. Food and Chemical Toxicology. 2004;42(1):45–9.
2.
Pickering RJ, Rosado CJ, A S. Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. Clin Transl Immunol. 2018;7:1016.
3.
Szocs K. Endothelial dysfunction and reactive oxygen species production in ischemia/ reperfusion and nitrate tolerance. Gen Physiol Biophys. 2004;23:265–96.
4.
Steven S, Münzel T, Daiber A. Exploiting the pleiotropic antioxidant effects of established drugs in cardiovascular disease. Int J Mol Sci. 2015;16:18185–223.
5.
Tomovic K, Ilic BS, Z S. Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors. Chem Biol Interact. 2020;315:108873.
6.
Roumeliotis S, Roumeliotis A, E D. Dietary antioxidant supplements and uric acid in chronic kidney disease: a review. Nutrients. 2019;11:1911.
7.
Feigelson Philip. THE INHIBITION OF XANTHINE OXIDASE IN VITRO BY TRACE AMOUNTS OF l-ASCORBIC ACID. Journal of Biological Chemistry. 1952;197(2):843–50.
8.
Gulcin İ. Antioxidants and antioxidant methods: an updated overview. Arch Toxicol. 2020;94:651–715.
9.
Vijayalakshmi M, Ruckmani K. Ferric reducing anti-oxidant power assay in plant extract. Bangladesh J Pharmacol. 2016;11:570–2.
10.
Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15–27.
11.
Apak R, Güclü K, M Ö. Mechanism of antioxidant capacity assays and the CUPRAC (cupric ion reducing antioxidant capacity) assay. Microchim Acta. 2008;160:413–9.
12.
Apak R, Özyürek M, Güçlü K, Çapanoğlu E. Antioxidant Activity/Capacity Measurement. 1. Classification, Physicochemical Principles, Mechanisms, and Electron Transfer (ET)-Based Assays. Journal of Agricultural and Food Chemistry. 2016;64(5):997–1027.
13.
Re R, Pellegrini N, A P. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26:1231–7.
14.
Miliauskas G, Venskutonis PR, van Beek TA. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chemistry. 2004;85(2):231–7.
15.
Brand-Williams W, Cuvelier ME, Berset CL. Use of a free radical method to evaluate antioxidant activity. LWT - Food Sci Technol. 1995;28:25–30.
16.
Mavrova ATs, Yancheva D, Anastassova N, Anichina K, Zvezdanovic J, Djordjevic A, et al. Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles. Bioorganic & Medicinal Chemistry. 2015;23(19):6317–26.
17.
Haida Z, Hakiman M. A comprehensive review on the determination of enzymatic assay and nonenzymatic antioxidant activities. Food Science & Nutrition. 2019;7(5):1555–63.
18.
Handbook of antioxidants. 2002.
19.
George J. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vascular Health and Risk Management. :265.
20.
Battelli MG, Polito L, Bolognesi A. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis. 2014;237:562–7.
21.
Togliatto G, Lombardo G, Brizzi MF. The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side. International Journal of Molecular Sciences. 18(9):1988.
22.
Pinchuk I, Shoval H, Dotan Y, Lichtenberg D. Evaluation of antioxidants: Scope, limitations and relevance of assays. Chemistry and Physics of Lipids. 2012;165(6):638–47.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
